community download

Presentation: Is yeast on the rise?

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Dr. Stephan Hellwig from Fraunhofer IME joined us at the World Vaccine Congress 2012 in Washington to answer the question: Is yeast on the rise?
 The Ama1 project from Fraunhofer IME is sponsored by the European Vaccine Initiative, leading the European effort to develop effective, accessible, and affordable vaccines against diseases of poverty. EVI’s vision:
“...a world free of the intolerable burden of diseases of poverty within the coming decades.”
The Ama1 project (Apical Membrane Antigen) induces broader allelic recognition and growth inhibition responses in Rabbits. The process of development of this project is an upstream process development to amend the post-IMAC stability issue and address purity issues. The scaleup and transfer GMP concerns the raw materials and consumables specification, as well as API specs and QC. In total, there are 3 GMP batches.
The Ama1 process takes place over 7 days: shake-flask cultivation, seed bioreactor, production bioreactor, centrifugation, filtration, IMAC, HIC, and finally buffer exchange.